On April 22, 2013 Farmak JSC gave to the public the consolidated financial statements for the year 2012 prepared in accordance with International Financial Reporting Standards (IFRS).
Viktoria Smarodina, Farmak’s Financial Director says, “For the last 6 years we have been auditing the consolidated financial statements. This year the Company’s management made the decision on publication of the financial statements for the year 2012. Thus, we demonstrate not only our responsibility under the requirements of Ukrainian legislation but adherence to the provisions determined in the Company’s business transparency strategy”.
The audit of Farmak consolidated financial statements was conducted by one of the Big Four companies – PJSC Delloitte and Touche Ukrainian Services Company. The report of independent auditors contains unqualified opinion on Farmak consolidated financial statements.
According to the consolidated financial statements, the revenue in the year 2012 amounts to UAH 1.692 Mio that by 15.2% exceeds the revenue in the year 2011 (UAH 1.468 Mio). Net profit for the year 2012 amounts to UAH 278 Mio comparing with UAH 248 Mio in the year 2011.
Each city or town has its own traditions. We follow the old and develop the new ones ourselves. It has become a good tradition for Farmak to congratulate Shostka on its Town Day in a sporty way. The anniversary race “Farmak: Run for Your Health” has been held by the Company for the fifth time. […]
The 5th anniversary race organized by Farmak on the occasion of Shostka Town Day will be held with the support of the local authorities in an offline format under the motto “Run a race and take care of your health!” The race will take place on September 3 in Shostka as part of the celebration of […]
TOP 50 successful Ukrainian brands with a stable reputation and a high level of customer confidence have been determined by the Focus expert magazine. Farmak as the Ukrainian pharmaceutical market leader is among the best. The rating includes both brand companies and brand products from different segments: retail, pharmaceuticals, food industry, telecommunic...